HGH
Von der FDA zugelassenHuman Growth Hormone | Somatropin
Human Growth Hormone (HGH/Somatropin) is a 191-amino acid polypeptide hormone FDA-approved for pediatric and adult growth hormone deficiency, HIV-associated wasting, and other conditions.
Molekulare und Forschungsdaten
- Molekulargewicht
- 22,124 Da
- Halbwertszeit
- 3-4 hours (SC), 20-30 minutes (IV)
- Primäre Ziele
- gh-direct, igf1
- Wege (Forschung)
- injectable
- Lagerung
- Lyophilized: Room temperature. Reconstituted: 2-8°C, use within 14-28 days
Overview
Human Growth Hormone (HGH/Somatropin) is a 191-amino acid polypeptide hormone FDA-approved for pediatric and adult growth hormone deficiency, HIV-associated wasting, and other conditions. It provides both direct and indirect (IGF-1 mediated) anabolic effects.
Mechanism of action
Binds to GH receptors on target tissues, triggering JAK2-STAT5 signaling pathway. Direct effects include lipolysis, protein synthesis, and metabolic regulation. Indirect effects via IGF-1 promote growth and anabolism. Half-life ~3 hours subcutaneously.
Key research findings
- Improved body composition (increased lean mass, decreased fat)
- Enhanced bone mineral density
- Improved lipid profile
- Increased exercise capacity
- Better quality of life and mood
- Skin, hair, and nail improvements
- Enhanced recovery and healing
Research applications
Growth Hormone Deficiency
- Pediatric GH Deficiency — FDA-approved for idiopathic and organic causes, Turner syndrome, Prader-Willi syndrome, SGA, Noonan syndrome, SHOX deficiency.
- Adult GH Deficiency — FDA-approved for childhood-onset or adult-onset causes (pituitary tumors, surgery, radiation, trauma).
- HIV-Associated Wasting — FDA-approved to increase lean body mass and body weight in cachexia.
Body Composition
- Fat Loss — Significant fat loss especially abdominal/visceral fat over 1-3 months.
- Lean Mass — Increased muscle mass and improved body composition.
- Recovery Enhancement — Enhanced exercise recovery and tissue healing.
Anti-Aging
- Skin and Hair Quality — Improved skin elasticity, texture, and hair/nail growth.
- Energy and Well-being — Improved energy, sleep, and quality of life.
HGH Häufig gestellte Fragen
Will HGH unmask thyroid problems?+
Yes. HGH unmasks central hypothyroidism in 36-47% of users by increasing T4-to-T3 conversion. Get baseline thyroid labs (TSH, free T4, free T3) before starting and recheck at 6-8 weeks. Many users need T4 supplementation while on HGH.
How much carpal tunnel syndrome should I expect from HGH?+
Carpal tunnel symptoms are common (10-30% of users) and typically mild to moderate. They usually resolve with dose reduction. Symptoms typically peak at 2-4 weeks and improve as your body adapts. Starting low and titrating up reduces risk.
Does HGH require continuous use or can I cycle it?+
HGH effects are dose-dependent and reversible. Most users cycle 3-6 months on, 1-2 months off to maintain sensitivity and allow recovery of natural GH production. Continuous use is possible but may increase side effect risk over time.
Can HGH cause diabetes?+
HGH decreases insulin sensitivity, potentially unmasking pre-diabetes or causing diabetes in susceptible individuals. Monitor fasting glucose and HbA1c regularly. Those with family history of diabetes should proceed cautiously and may need metformin support.
References
- [1]Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15,809 GH-Treated PatientsJournal of Clinical Endocrinology & Metabolism
- [2]Efficacy and Safety of Growth Hormone Treatment in Adults with Growth Hormone Deficiency: A Systematic Review of Studies on MorbidityClinical Endocrinology
- [3]Cardiovascular Risk in Growth Hormone Deficiency: Beneficial Effects of Growth Hormone Replacement TherapyEndocrine
- [4]Unmasking of Central Hypothyroidism Following Growth Hormone Replacement in Adult Hypopituitary PatientsClinical Endocrinology
- [5]A 2024 Update on Growth Hormone Deficiency Syndrome in Adults: From Guidelines to Real LifeJournal of Endocrinological Investigation
- [6]Developments in the Management of Growth Hormone Deficiency: Clinical Utility of SomapacitanDrug Design, Development and Therapy
Verwandte Peptide
CJC-1295 with DAC
Well studiedLong-Acting Growth Hormone Releasing Hormone Analog | Extended Release
Modified growth hormone releasing hormone engineered for extended duration via albumin-binding technology. DAC binds to albumin, extending half-life and providing continuous GHRH receptor stimulation.
CJC/IPA Protocol
Well studiedGHRH/GHRP Combination | Growth Hormone Optimization
A dual-pathway protocol combining CJC-1295 and Ipamorelin that targets growth hormone secretion through complementary mechanisms.
IGF-1 LR3
Limited researchModified Growth Factor Analog | Muscle Growth
IGF-1 LR3 is a synthetic 83-amino acid analog of insulin-like growth factor-1 that has never been approved for human use.
MGF
Limited researchMechano Growth Factor | IGF-1 Splice Variant
Non-pegylated IGF-1 splice variant produced locally in muscle tissue following mechanical stress.